SNORD114-23: A promising drug target and biomarker for small nucleolar RNA (snRNA)

Target Name: SNORD114-23

NCBI ID: G767603

SNORD114-23

Other Name(s): Small nucleolar RNA, C/D box 114-23 | small nucleolar RNA, C/D box 114-23 | 14q(II-23)

SNORD114-23: A promising drug target and biomarker for small nucleolar RNA (snRNA)

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the key classes of snRNA is the C/D box snRNA (C/D box snRNA), which is characterized by the presence of a specific base-pairing pattern in its secondary structure. C/D box snRNA are highly conserved across different organisms and are involved in various cellular processes, including DNA replication, transcription, and regulation of gene expression.

One of the most promising drug targets in the field of snRNA is SNORD114-23. SNORD114-23 is a C/D box snRNA that is expressed in a variety of tissues and cells, including muscle, heart, and tests. It has been shown to play a role in the regulation of gene expression and has been implicated in a number of cellular processes, including muscle growth, protein synthesis, and DNA replication.

One of the key reasons why SNORD114-23 is considered a promising drug target is its expression in a variety of tissues and cells. This makes it an attractive target for drugs that can modulate its expression levels and/or activity. Additionally, its expression is often regulated by post-transcriptional modifications (RNA modifications), such as RNA-binding protein (RBP) binding and phosphorylation, which can be targeted by small molecules or CRISPR/Cas9 genome editing.

Another reason why SNORD114-23 is a promising drug target is its role in the regulation of gene expression. SNORD114-23 has been shown to play a role in the regulation of muscle protein synthesis and muscle growth. Additionally, it has been shown to be involved in the regulation of cardiac function and heart rate. These functions make SNORD114-23 an attractive target for drugs that can modulate its expression levels and/or activity to treat a variety of diseases, including muscle-related diseases and cardiac function disorders.

In addition to its role in gene expression, SNORD114-23 has also been shown to play a role in the regulation of DNA replication. DNA replication is a critical process for the growth and maintenance of organisms, and SNORD114-23 has also been shown to play a role in the regulation of DNA replication in various organisms.

Overall, SNORD114-23 is a promising drug target due to its expression in a variety of tissues and cells, its role in the regulation of gene expression, and its involvement in the regulation of DNA replication. Further research is needed to fully understand the molecular mechanisms of SNORD114-23 and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: Small Nucleolar RNA, C/D Box 114-23

The "SNORD114-23 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-23 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets